Acadia Healthcare (NASDAQ:ACHC) Updates FY 2026 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.450-1.600 for the period, compared to the consensus estimate of 1.510. The company issued revenue guidance of $3.4 billion-$3.5 billion, compared to the consensus revenue estimate of $3.4 billion.

Acadia Healthcare Trading Down 1.4%

Shares of Acadia Healthcare stock traded down $0.39 during mid-day trading on Thursday, hitting $26.96. The stock had a trading volume of 425,628 shares, compared to its average volume of 3,353,892. The firm has a 50-day moving average of $28.00 and a two-hundred day moving average of $23.59. The firm has a market cap of $2.48 billion, a P/E ratio of -2.17, a price-to-earnings-growth ratio of 10.90 and a beta of 0.64. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 5.95% and a negative net margin of 33.44%.The firm had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. During the same period last year, the company earned $0.83 EPS. The company’s quarterly revenue was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Sell-side analysts forecast that Acadia Healthcare will post 1.5 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ACHC. TD Cowen increased their price target on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Royal Bank Of Canada upped their target price on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. Guggenheim raised their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a report on Thursday. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the stock from $24.50 to $30.00 in a research note on Wednesday, June 3rd. Finally, Cantor Fitzgerald reissued a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Acadia Healthcare currently has an average rating of “Hold” and an average target price of $29.85.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the stock. Goldman Sachs Group Inc. increased its position in Acadia Healthcare by 417.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares in the last quarter. Wellington Management Group LLP grew its stake in Acadia Healthcare by 24.9% in the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after acquiring an additional 2,350,760 shares during the period. Deerfield Management Company L.P. acquired a new position in Acadia Healthcare in the 3rd quarter valued at $29,440,000. Rubric Capital Management LP purchased a new position in shares of Acadia Healthcare during the 3rd quarter worth $27,236,000. Finally, Capitolis Liquid Global Markets LLC acquired a new stake in shares of Acadia Healthcare during the fourth quarter worth $8,954,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.